These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
649 related articles for article (PubMed ID: 17020613)
1. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells. Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613 [TBL] [Abstract][Full Text] [Related]
2. Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway. Fuerer C; Iggo R Gene Ther; 2002 Feb; 9(4):270-81. PubMed ID: 11896466 [TBL] [Abstract][Full Text] [Related]
3. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. Li B; Liu X; Fan J; Qi R; Bo L; Gu J; Qian Q; Qian C; Liu X J Gene Med; 2006 Oct; 8(10):1232-42. PubMed ID: 16900558 [TBL] [Abstract][Full Text] [Related]
4. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy. Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895 [TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE; Wang MX; Li RQ Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933 [TBL] [Abstract][Full Text] [Related]
6. Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Benhaj K; Akcali KC; Ozturk M Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433 [TBL] [Abstract][Full Text] [Related]
7. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. Kuroda T; Rabkin SD; Martuza RL Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077 [TBL] [Abstract][Full Text] [Related]
8. RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer. Homicsko K; Lukashev A; Iggo RD Cancer Res; 2005 Aug; 65(15):6882-90. PubMed ID: 16061672 [TBL] [Abstract][Full Text] [Related]
9. An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated wnt signaling. Toth K; Djeha H; Ying B; Tollefson AE; Kuppuswamy M; Doronin K; Krajcsi P; Lipinski K; Wrighton CJ; Wold WS Cancer Res; 2004 May; 64(10):3638-44. PubMed ID: 15150123 [TBL] [Abstract][Full Text] [Related]
10. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S; Bapat B Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999 [TBL] [Abstract][Full Text] [Related]
11. Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway. Brunori M; Malerba M; Kashiwazaki H; Iggo R J Virol; 2001 Mar; 75(6):2857-65. PubMed ID: 11222711 [TBL] [Abstract][Full Text] [Related]
12. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin. Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637 [TBL] [Abstract][Full Text] [Related]
13. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Takahashi M; Nakamura Y; Obama K; Furukawa Y Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202 [TBL] [Abstract][Full Text] [Related]
14. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells. Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019 [TBL] [Abstract][Full Text] [Related]
15. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667 [TBL] [Abstract][Full Text] [Related]
16. Drosophila split ends homologue SHARP functions as a positive regulator of Wnt/beta-catenin/T-cell factor signaling in neoplastic transformation. Feng Y; Bommer GT; Zhai Y; Akyol A; Hinoi T; Winer I; Lin HV; Cadigan KM; Cho KR; Fearon ER Cancer Res; 2007 Jan; 67(2):482-91. PubMed ID: 17234755 [TBL] [Abstract][Full Text] [Related]
17. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival. Alves-Guerra MC; Ronchini C; Capobianco AJ Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy approach in prostate cancer cells using an active Wnt signal. Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788 [TBL] [Abstract][Full Text] [Related]
19. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341 [TBL] [Abstract][Full Text] [Related]
20. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]